Exchange: NASDAQ·Updated 07:32 PM EST

WHWK Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 09

Estimated EPS

-$0.21

Reported EPS

-$0.23

Surprise

-7.33%

Estimated Rev

$0M

Reported Rev

---

Surprise

---

Whitehawk Therapeutics believes its $169.7M in cash, cash equivalents and short-term investments will enable planned operations into the second half of 2028, and does not expect revenue for the foreseeable future.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.22
--
--
N/A
Q3 '26
-$0.21
-$0.23
-7.33%
MISSED
Q2 '26
-$0.30
-$0.20
32.37%
BEAT
Q1 '26
-$0.36
-$0.32
10.49%
BEAT
Q4 '25
-$0.48
-$0.34
29.55%
BEAT

Advertisement|Remove ads.